Navigation Links


Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation

4/25/2015
LONDON , 25. April 2015 Hospira, Inc. (NYSE: HSP ), ein Weltführer in der Entwicklung von Biosimilar-Behandlungen, sprach heute auf der jährlichen Konferenz der Europäischen Biosimilars Gruppe des Europäischen Generikaverbands (EGA) in London über die Bedeutung von Extrapolation im Zusammenhang mit der Verfügbarkeit von Biosimilars für... [Comments]

New Leksell Gamma Knife to benefit more patients with brain disease

4/25/2015
BARCELONA, Spain , April 25, 2015  With the introduction of Elekta's new Leksell Gamma Knife® Icon™, the benefits of precision cranial radiosurgery are now available for more patients with a wider variety of tumor types and sizes. This latest generation stereotactic radiosurgery system for the brain, integrates advanced motion management, dose delivery and imagi... [Comments]

Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein

4/24/2015
NASHUA, New Hampshire , und BARCELONA , Spanien, 24. April 2015 (Stand Nr. 4410) iCAD, Inc. (Nasdaq: ICAD ), ein branchenweit führender Anbieter von moderner Bildanalyse, Lösungen für Behandlungsabläufe und Strahlentherapie für die Früherkennung und Behandlung von Krebserkrankungen, hat heute die sofortige Verfügbarkeit des ersten Xoft &#... [Comments]

Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch

4/24/2015
DRAPER, Utah , April 24, 2015 Today, humanity takes a massive step toward reaching our shared dreams of jetpacks, hoverboards, the singularity, and fat-free cronuts: 1-800 CONTACTS announces their new Apple Watch app which allows the reordering of contact lenses in just two taps. Two taps. New contacts. From your watch. We live in the future . The app also features LensGa... [Comments]

Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc.

4/24/2015
NEW YORK , April 24, 2015   Bernstein Liebhard LLP is investigating whether (i) Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") (NASDAQ: AERI ) issued materially false and misleading statements to investors in violation of the federal securities laws; or (ii) the Board of Directors of Aerie breached their fiduciary duties to shareholders. Aerie is a clinical-sta... [Comments]

Perrigo Rejects Mylan Unsolicited Offer

4/24/2015
DUBLIN , April 24, 2015  Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO, TASE) today announced its rejection of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL ) to acquire all of the outstanding shares of Perrigo for $60.00 per share in cash and 2.2 Mylan ordinary shares for each ordinary Perrigo share (the "Offer").  The Board previously... [Comments]

Expanding Naloxone use could reduce drug overdose deaths and save lives

4/24/2015
ATLANTA , April 24, 2015 Allowing more basic emergency medical service (EMS) staff to administer naloxone could reduce drug overdose deaths that involve opioids, according to a Centers for Disease Control and Prevention (CDC) study, "Disparity in Naloxone Administration by Emergency Medical Service Providers and the Burden of Drug Overdose in Rural Communities," pub... [Comments]

Bayer Hosts "Take Your Child to Work Day"

4/24/2015
WHIPPANY, N.J. , April 24, 2015  Bayer Corporation hosted its annual "Take Your Child to Work Day" on Thursday, April 23 at the Bayer HealthCare US headquarters.  This is Bayer's second "Take Your Child To Work Day" since relocating to the Whippany campus, and Thursday's event welcomed 230 children ready to see what Mom and Dad do every day at work. Fortunately,... [Comments]

Researchers find alarming rise in cost of MS drugs over past two decades

4/24/2015
PORTLAND, Ore. , April 24, 2015  A new study shows an "alarming rise" over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks, according to a study led by researchers at Oregon Health & Science University (OHSU) and Oregon State University (OSU). A substantial increase in the number of MS drug... [Comments]

IGI Laboratories To Hold Conference Call For 1st Quarter 2015 Results

4/24/2015
BUENA, N.J. , April 24, 2015  IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on Tuesday, April 28, 2015 to discuss the 1st quarter 2015 results. The Company invites you to listen to the call by dialing 1-888-346-3479. International participants should... [Comments]

[next]
(Date:4/25/2015)... (PRWEB) April 25, 2015 In the ... twelve and above needed treatment for an illicit ... the Substance Abuse and Mental Health Services Administration’s Survey ... Beyond these alarming numbers are harrowing stories of men ... substance abuse . David H. Kerr , founder ...
(Date:4/25/2015)... By definition, a CIO’s responsibility is to support the ... their judgement and expertise to keep digital assets and environments ... article published in National Mortgage News on April 22nd, 2015 ... to their responsibilities by focusing too heavily on making sure ... it comes to company policy and industry best practices, and ...
(Date:4/25/2015)... Bradley, Illinois (PRWEB) April 25, 2015 ... life enrichment and wellness, management and operations, and ... Annual Meeting and Exhibition scheduled to be held ... Illinois. , LeadingAge Illinois is the largest eldercare ... leading providers of services for older adults, including ...
(Date:4/25/2015)... Portland, OR (PRWEB) April 25, 2015 Sports controversies ... occur within team confines, as was the case with the Miami ... the team as seen in the Ray Rice domestic abuse case. ... Steele of Sporting News discusses the implications of locker room ... their response and what other teams should do to improve the ...
(Date:4/24/2015)... April 24, 2015 Bird B Gone, the ... applications now offers a complete line of bird control solutions ... farms. , New Flu Strains Threaten Pacific, Central and Mississippi ... post , a number of highly pathogenic avian flus ... disease is often spread when wild birds enter poultry farms. ...
Breaking Medicine News(10 mins):Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:David Steele Discusses Locker Room Culture on SCI TV 2Health News:David Steele Discusses Locker Room Culture on SCI TV 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4
... back, the 2008 Compensation Data results show benefits have seen little change ... ... October 29, 2008 -- General Motors has made headlines with plans to ... Retirees are also slated to loose health insurance coverage when they reach ...
... commercial with Jenny,Craig celebrity client, Valerie Bertinelli, ... pleased to,announce the three grand finalists of their ... Elaina Faustino and,Sara Hennessy are the three women ... TV commercial with Jenny Craig star client, Valerie ...
... (Nasdaq: WHRTD ) --,World Heart Corporation (WorldHeart or ... filing of articles of amendment with Industry,Canada under the ... Capital Market on a post-consolidation basis on October 28,2008. ... split at a Special Meeting of Shareholders held on ...
... Quarter Net Sales of $3.9 Million; 29% Increase ... - Second Fiscal Quarter U.S. Sales of $2.2 Million; 83% Increase ... Year-Over-Year -, - Multicenter Clinical Study Launched to Expand Reimbursement, Support ... Marketing - - Conference Call to be Held ...
... Oct. 29 Heralding the newest innovation,in home skin ... of light therapy, has announced the retail launch of ... Quasars are widely,acclaimed as the first professional devices made ... the Baby Quasar delivers exceptional,skin care results and can ...
... cloud symptoms, study says , , WEDNESDAY, Oct. 29 (HealthDay News) ... in people if they have other medical conditions, a new ... high cholesterol appeared to mask early MS symptoms and lead ... in the Oct. 29 online issue of Neurology . ...
Cached Medicine News:Health News:Cuts at General Motors Bring Benefit Trends to the Forefront 2Health News:Cuts at General Motors Bring Benefit Trends to the Forefront 3Health News:Jenny Craig Announces Finalists for the 2008 Ideal Size Contest 2Health News:WorldHeart Announces Effectiveness of Reverse Stock Split 2Health News:WorldHeart Announces Effectiveness of Reverse Stock Split 3Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 2Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 3Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 4Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 5Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 6Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 7Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 8Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 9Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 10Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 11Health News:Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009 12Health News:Baby Quasar Lights Up Dillard's for the Retail Holiday Season 2Health News:Other Health Problems Can Delay MS Diagnosis 2
... The primary objective of the BioPro Toe ... that will relieve pain and restore motion ... foot undisturbed. The procedure used to implant ... bone resection. , ,The design for the ...
... Electrodes provide direct cranial nerve monitoring ... circumferential design provides sensitive contact on ... real-time recordings. This unique approach provides ... removal of acoustic neuromas, microvascular decompressions, ...
... Ad-Techs Intraoperative Electrodes share similar ... The main difference is that ... are numbered to assist you ... are designed for use with ...
... As with all of Ad-Techs products, our Sphenoidal ... quality. They are available in stainless steel or ... or 2.75 inch (70 mm) long, 21 gauge ... electrodes are supplied as kits or sets. You ...
Medicine Products:
(Date:4/24/2015)... , April 24, 2015 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products and ... Marihuana for Medical Purposes Regulations ( Canada ... with certain of its shareholders, has closed the transaction ... ("Medna").  Medna has acquired (the "Escrow Transfer") a total ...
(Date:4/24/2015)... -- Elekta has CE marked the latest version (v5.10) of ... European clinics to deliver a sophisticated radiation therapy planning ... planning, IMRT, VMAT and stereotactic planning – all in ... ® v5.10 provides significant planning and ... 3D planning as well as the addition of MRI ...
(Date:4/23/2015)... CHICAGO, Ill. , April 24, 2015  AbbVie ... Food and Drug Administration (FDA) has accepted its New ... company,s, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, ... for the treatment of adults with chronic genotype 4 ... regimen is the first all-oral, interferon-free therapy being evaluated ...
Breaking Medicine Technology:T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3Elekta CE marks for Monaco v5.10 treatment planning system 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7
... Knopp Neurosciences Inc. ("Knopp"),announced that the U.S. ... Development has granted orphan drug designation to ... (ALS). (Logo: http://www.newscom.com/cgi-bin/prnh/20070924/KNOPPLOGO ) ... studies to evaluate the safety,tolerability and pharmacokinetics ...
... on stringent endpoint of clinical ... PHILADELPHIA, Oct. 15 An analysis of data to,be ... Scientific Meeting found that Asacol, dosed at 2.4 g/day, ... active,ulcerative colitis (UC). The analysis was based on data ...
Cached Medicine Technology:Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS 2New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 2New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 3New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 4